Merck Stock Hits New High; Dow Outperformsby Mark Eisenberg 28.03.2024Stock and bond markets will be closed on Good Friday. Get expert advice straight to your e-mail for profitable opportunities. ...
AI Stocks Drop as Intel, AMD, and Apple Drive Demand for 3nm Chipsby Lilu Anderson 28.03.2024Most AI stocks, including Intel, are currently falling due to pressures from key customers and demand for 3nm chips. This ...
Eco Wave Power Global AB (publ) Financial Report: Revenue Growth Potential?by Terry Bingman 28.03.2024Eco Wave Power Global AB (publ) is a wave energy company facing financial challenges, yet offers growth potential with innovative ...
Top 3 Mega-Cap Stocks: Outperform the Marketby Mark Eisenberg 28.03.2024Picking top mega-cap stocks may lead to outperforming the market. Amazon and Meta Platforms have strong Wall Street support and ...
Ichor Holdings, Ltd.: Semiconductor Equipment Leader?by John Darbie 28.03.2024Ichor Holdings, Ltd. is a semiconductor equipment company with positive earnings outlook and a "Buy" rating from analysts. Target price ...
Astronics Corporation: Financial Report Analysisby Terry Bingman 28.03.2024Explore the financial report of Astronics Corporation in the aerospace & defense sector, with a market cap of $627.77 million. ...
OptiNose, Inc.: Financial Report Reveals Stabilityby Mark Eisenberg 28.03.2024OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Workhorse Group Inc.: Financial Performance Analysisby Terry Bingman 28.03.2024Discover the financial report of Workhorse Group Inc. (WKHS), a technology company specializing in zero-emission commercial vehicles. Despite revenue growth, ...
Cohere: A Major Contender in Generative AI Raceby Lilu Anderson 28.03.2024Canadian startup Cohere is a major contender among tech giants Google, Meta, HP, Anthropic, and Mistral in developing their own ...
Ventyx Biosciences: Financial Report Reveals Growth Challengesby Terry Bingman 28.03.2024Ventyx Biosciences, Inc. (VTYX) is a high-risk investment with negative net income and high debt ratio, but analysts recommend buying ...